Biocon Subsidiary Secures USFDA Approval
Biocon Biologics, a subsidiary of Biocon, reported on Thursday, 10 April, that the US Food and Drug Administration (FDA) had approved its antibody Jobevne. The...
Tag : Biocon Ltd.
Biocon Shares Shot Up 3% on Securing Final Approvals from USFDA
Shares of pharmaceutical major Biocon Ltd were trading in the green and 3% higher on 5 March after the company that its wholly-owned subsidiary secured...
Biocon Shares Slip 4% on Launching Liraglutide in the UK
Shares of Biocon Ltd slipped 4% on Friday, 28 February, after the company announced that their Glucagon-like Peptide-1 (GLP-1) equivalent, Liraglutide, would be made available...
Biocon Shares Surg 8% as Subsidiary Gets Approval for Psoriasis Drug
Shares of Biocon Ltd surged 8% on 7 December after the company’s subsidiary, Biocon Biologics, announced approval from Japan’s Pharmaceuticals and Medical Devices Agency. The...
Biocon Shares Rally 4% as Subsidiary Receives USFDA Approval
Shares of Biocon rallied 4% on Monday, 2 December, after the company announced that its subsidiary, Biocon Biologics, had received approval from the US Food...
Shares of Biocon Ltd surge over 3.54% per cent on strong December quarter numbers. What’s Ahead?
Biocon Ltd NSE :BIOCON BSE :532523 Sector : Pharmaceuticals About Company: Biocon is engaged in the business of manufacture of biotechnology products and research services. Has one of the...
Why Biocon Share Price Gained 6.27% Today? What’s Ahead?
Biocon Ltd NSE :BIOCON BSE :532523 Sector : Pharmaceuticals About Company: Biocon Limited is an Indian biopharmaceutical company that is based in Bangalore, India founded by Kiran Mazumdar-Shaw. The...
Biocon’s Q4 Slips Due to Logistics; Stock Under Pressure
The disruption in business due to covid-19 has proven to be acute for Biocon Ltd. With its Q4 figures trailing far behind Street estimates, the...
